Hong Kong Stock Movement | Keymed Biosciences-B (02162.HK) Rises Over 5%; Kangyueda Continues to Ramp Up Within Medical Insurance; Clinical Data for Self-Developed CDH17 ADC CM518D1 Selected for ESMO
Zhitong Finance APP has learned that Keymed Biosciences-B (02162.HK) rose more than 5%. As of press time, it was up 5.12% at HK$83.15, with a turnover of HK$149 million.
Latest
5 m ago
